Utilization of Fund to Improve Profitability of Multinational Companies in Indian Pharmaceutical Sector: A Study
Liberalization of the Indian economy in 1991 exposed the Indian pharmaceutical industry to intensified compitation from multinational corporation. Further, India's signing of the Trade Related Intellect property Rights Systems (TRIPS) agreement compelled the industry to look at growth driven by product innovation. In this backdrop, survival of the multinational companies in the Indian pharmaceutical sector requires efficient fund management which is an integral part of the overall corporate strategy to create shareholder value. Although during the last four decades in US, UK and some other developed countries a considerable number of studies have been conducted on the evaluation of the interrelationship between mangement of fund and profitability, this important issue has not been considered with due important in India. Furthermore, no study in connection with this unresolved issue has yet been mude during the post-liberalization era on multinational pharmaceutical companies in India. In this context, the present paper makes an attempt to examine empirically the performance of the Indian pharmaceutical industry during the post-liberation era in reference to the relationship between fund management and profitability of ten selected multinational pharmaceutical companies belongs to the Indian private sector during the period l1999-2000 to 2008-09. The data used in this pertains to the year end figures of each financial year under study. The study tries to account for the effects of the liberalization refoms curried ouf in the f990s, which ean'b be disced clearly during the initial years of the pefomw. Therefore, the financial year 1999-2000 has been treated as the initial year of the period under study. The issue has been tackled using releuant statistical tools and techniques.